Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals
- 1 September 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 13 (6) , 513-518
- https://doi.org/10.1097/00001721-200209000-00006
Abstract
Separate reports have identified differences in plasma levels of the endothelial markers soluble E-selectin, von Willebrand factor (vWf) and soluble thrombomodulin in each of the major modifiable risk factors for atherosclerosis (smoking, hypertension and hypercholesterolaemia), and abnormal levels of some plasma markers predict various adverse cardiovascular events. However, it is unclear whether there is an increasing effect on the endothelium with a worsening risk-factor profile. We measured the three endothelial cell markers by enzyme-linked immunosorbent assay in the plasma of 200 subjects (mean age, 54 years; 58% men) free of the symptoms and clinical signs of atherosclerosis. Levels of the markers were then correlated with the Framingham coronary heart disease (CHD) and cerebrovascular disease (CVD) scores to help determine which (if any) may be useful as good laboratory predictors of future cardiovascular events in prospective epidemiological studies. vWf correlated with CHD (rs = 0.269, P rKeywords
This publication has 38 references indexed in Scilit:
- Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysisThe Lancet, 2001
- Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery StudyBlood Coagulation & Fibrinolysis, 2000
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?Published by Oxford University Press (OUP) ,1997
- State-of-the-Art Review: Usefulness of Laboratory Techniques for Evaluating Antithrombotic Efficacy of New Therapeutic StrategiesClinical and Applied Thrombosis/hemostasis, 1995
- Increase in Circulating Products of Lipid Peroxidation (F2-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative DamageNew England Journal of Medicine, 1995
- Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive diseaseEuropean Journal of Clinical Investigation, 1995
- Relations between hemostasis variables and cardiovascular risk factors in middle-aged adultsAnnals of Epidemiology, 1992
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991
- An in vitro model for the study of acute release of von Willebrand factor from human endothelial cellsBritish Journal of Haematology, 1987